4//SEC Filing
Shabahang Shahrokh 4
Accession 0001213900-21-030557
CIK 0001726711other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:37 PM ET
Size
5.0 KB
Accession
0001213900-21-030557
Insider Transaction Report
Form 4
Shabahang Shahrokh
DirectorCHIEF INNOVATION OFFICER
Transactions
- Purchase
Common Stock
2021-06-01$2.93/sh+490$1,436→ 1,016,098 total(indirect: By son)
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Aditx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001816754
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:37 PM ET
- Size
- 5.0 KB